Abstract:Subtle differences oppose CD4+ to CD8+ T cell physiologies that lead to different arrays of effector functions. Interestingly, this dichotomy has also unexpected practical consequences such as the inefficacy of many MHC class II tetramers in detecting specific CD4+ T cells. As a mean to study the CD4+ anti-OVA response in H-2d and H-2b genetic backgrounds, we developed I-Ad- and I-Ab-OVA recombinant MHC monomers and tetramers. We were able to show that in this particular system, despite normal biological activ… Show more
“…Such aAPC were very efficient in identifying class II-restricted Ag-specific T cells but their capacity to effectively stimulate T cells was limited to some highaffinity T cell hybridomas which do not require costimulation. As also suggested by elegant work from others (18), using similar technology, suboptimal stimulatory capacity was presumably due to the combination of several factors, including inappropriate orientation of MHC molecules, lack of organization, and insufficient local concentration of T cell ligands in the area of contact between the aAPC and T cell. Taken together, these data show that the efficiency of these artificial systems in inducing T cell activation may be influenced by the relative density of MHC-peptide complexes available at the point of interaction.…”
T cell activation is associated with active clustering of relevant molecules in membrane microdomains defined as the supramolecular activation cluster. The contact area between these regions on the surface of T cells and APC is defined as the immunological synapse. It has been recently shown that preclustering of MHC-peptide complexes in membrane microdomains on the APC surface affects the efficiency of immune synapse formation and the related T cell activation. Disruption of such clusters may reduce the efficiency of stimulation. We describe here an entirely artificial system for Ag-specific, ex vivo stimulation of human polyclonal T cells (artificial APC (aAPC)). aAPC are based on artificial membrane bilayers containing discrete membrane microdomains encompassing T cell ligands (i.e., appropriate MHC-peptide complexes in association with costimulatory molecules). We show here that preclustering of T cell ligands triggered a degree of T cell activation significantly higher than the one achieved when we used either soluble tetramers or aAPC in which MHC-peptide complexes were uniformly distributed within artificial bilayer membranes. This increased efficiency in stimulation was mirrored by increased translocation from the cytoplasm to the membrane of protein kinase θ, a T cell signaling molecule that colocalizes with the TCR within the supramolecular activation cluster, thus indicating efficient engagement of T cell activation pathways. Engineered aAPC may have immediate application for basic and clinical immunology studies pertaining to modulation of T cells ex vivo.
“…Such aAPC were very efficient in identifying class II-restricted Ag-specific T cells but their capacity to effectively stimulate T cells was limited to some highaffinity T cell hybridomas which do not require costimulation. As also suggested by elegant work from others (18), using similar technology, suboptimal stimulatory capacity was presumably due to the combination of several factors, including inappropriate orientation of MHC molecules, lack of organization, and insufficient local concentration of T cell ligands in the area of contact between the aAPC and T cell. Taken together, these data show that the efficiency of these artificial systems in inducing T cell activation may be influenced by the relative density of MHC-peptide complexes available at the point of interaction.…”
T cell activation is associated with active clustering of relevant molecules in membrane microdomains defined as the supramolecular activation cluster. The contact area between these regions on the surface of T cells and APC is defined as the immunological synapse. It has been recently shown that preclustering of MHC-peptide complexes in membrane microdomains on the APC surface affects the efficiency of immune synapse formation and the related T cell activation. Disruption of such clusters may reduce the efficiency of stimulation. We describe here an entirely artificial system for Ag-specific, ex vivo stimulation of human polyclonal T cells (artificial APC (aAPC)). aAPC are based on artificial membrane bilayers containing discrete membrane microdomains encompassing T cell ligands (i.e., appropriate MHC-peptide complexes in association with costimulatory molecules). We show here that preclustering of T cell ligands triggered a degree of T cell activation significantly higher than the one achieved when we used either soluble tetramers or aAPC in which MHC-peptide complexes were uniformly distributed within artificial bilayer membranes. This increased efficiency in stimulation was mirrored by increased translocation from the cytoplasm to the membrane of protein kinase θ, a T cell signaling molecule that colocalizes with the TCR within the supramolecular activation cluster, thus indicating efficient engagement of T cell activation pathways. Engineered aAPC may have immediate application for basic and clinical immunology studies pertaining to modulation of T cells ex vivo.
“…However, both flTCR-and scTCR-transduced primary T cells were stained poorly with the dimer (data not shown). In the future, we plan to try an improved tetramer technology 36 to identify the differential affinity between flTCR and scTCR. Holler et al 37 demonstrated that the low affinity of scTCR molecules could be dramatically increased by an in vitro selection system through site-directed mutagenesis.…”
Genetic modification of T lymphocytes with T-cell receptor (TCR) genes provides a novel tool for adoptive immunotherapy. However, the efficiency of full-length TCR (flTCR)-transduced T cells could be limited by factors such as incorrect pairing between exogenous and endogenous TCR chains and downregulation of the CD3 complex. To overcome these hurdles, one promising strategy is to use three-domain single-chain TCRs (3D-scTCR), in which TCR Va and Vb chains are joined by a linker with signal transduction domains fused at the carboxyl termini as signal transducers and amplifiers. Our results showed that surface expression of scTCRs on T cells after retroviral transduction was affected by the origin of the transmembrane (TM) region and placement of signaling domains. scTCR-modified T cells were functional as shown by cytokine (IL-2 and IFN-g) release in response to antigen stimulation and cytolytic activity against specific target cells. CD8 and CD28, but not the complete CD3 complex, could enhance the scTCR-induced T cell activation. Compared with flTCR-modified T cells and native CTLs, scTCR-modified T cells require higher thresholds of antigen stimulation (B10 À8 M peptide) to be functional. Despite the low efficiency of scTCRs, our data provide insight into further improvements in generating efficient scTCRs for in vivo applications.
“…2B, in general, 90% of the p31-I-A g7 -expanded T reg population failed to stain for the p31-I-A g7 multimer when analyzed by flow cytometry. It was possible that the unstained population was comprised of p31-I-A g7 -reactive cells with TCRs with too low of an affinity to be detected by flow cytometry (14). Alternatively, this population could be comprised of cells that were expanding in an Ag-nonspecific manner.…”
Section: Rare Ag-specific T Reg Can Be Expanded From Wild-type Nod Micementioning
confidence: 99%
“…The 1040-31 peptide, specific for BDC2.5 TCR Tg ϩ T cells, consisted of amino acids YVRPLWVRME (9). The HEL [11][12][13][14][15][16][17][18][19][20][21][22][23][24][25] protein consisted of amino acids AMKRHGLDNYRGYSL. GAD 286 -300 was a gift from E. Sercarz (Torrey Pines Institute for Molecular Studies, San Diego, CA).…”
CD4+CD25+Foxp3+ regulatory T cells (Treg) are critical for controlling autoimmunity. Evidence suggests that Treg development, peripheral maintenance, and suppressive function are dependent on Ag specificity. However, there is little direct evidence that the Treg responsible for controlling autoimmunity in NOD mice or other natural settings are Ag specific. In fact, some investigators have argued that polyclonal Ag-nonspecific Treg are efficient regulators of immunity. Thus, the goal of this study was to identify, expand, and characterize islet Ag-specific Treg in NOD mice. Ag-specific Treg from NOD mice were efficiently expanded in vitro using IL-2 and beads coated with recombinant islet peptide mimic-MHC class II and anti-CD28 mAb. The expanded Ag-specific Treg expressed prototypic surface markers and cytokines. Although activated in an Ag-specific fashion, the expanded Treg were capable of bystander suppression both in vitro and in vivo. Importantly, the islet peptide mimic-specific Treg were more efficient than polyclonal Treg in suppressing autoimmune diabetes. These results provide a direct demonstration of the presence of autoantigen-specific Treg in the natural setting that can be applied as therapeutics for organ-specific autoimmunity.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.